Q3 2025 Earnings Call October 24, 2025 8:30 AM EDTCompany ParticipantsThomas Larsen - Head of Investor RelationsPaul Hudson - CEO ...

Patients with rheumatoid arthritis-associated lung disease demonstrate a significant increased risk for serious infection vs.

Patients with rheumatoid arthritis increased their leg muscle volume when treated with an anti-rheumatic drug, offering new hope for improved muscle health.

Persistent exposure to certain insecticides and pesticides may increase the risk for rheumatoid arthritis among women, ...

Rheumatoid arthritis is a chronic autoimmune condition that cannot be cured but can be treated to prevent its progression. Individuals at risk of developing rheumatoid arthritis can be identified 3-5 ...

People who develop rheumatoid arthritis experience changes to their immune systems long before their joints become swollen and painful, suggesting that early treatment might stop or limit damage, a ...

Weight loss drugs known as GLP-1 receptor agonists are sometimes referred to as “miracle drugs,” not only because they help people lose weight, but because they’ve also been shown to help with many ...

Glucagon-like peptide 1 receptor agonists (GLP-1RA) have made waves as treatments for obesity and type 2 diabetes, but a new report suggests they might also have clinical benefits for certain patients ...

An invisible storm brews in the bodies of people developing rheumatoid arthritis They experience widespread systemic inflammation before any joint pain develops These patients also experience specific ...

A comprehensive, multi-phase investigation published in Advanced Science suggests that the amino acid tryptophan (Trp) may be a key determinant of therapeutic response to conventional synthetic ...